Future studies in larger cohorts will determine whether the presence of specific proteins known to influence the FAK signaling pathway in circulating EVs from YWBC and postmenopausal breast cancer patients is related to age of diagnosis, disease state, parity status, clinical outcomes, or response to treatment. This evidence concerns the gene PTK2 and breast cancer.